Product Program year 2020 Source: CMS Open Payments

Xience V coronary stent system

Device Vascular

Open in the dashboard

General payments

$3,996,919

6,512 payments

Research payments

$4,860,541

777 payments

Through program year 2020, $3,996,919 in general payments and $4,860,541 in research payments were reported against Xience V coronary stent system (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $1,031,286 1,395
2020 Research $569,822 49
2019 General $2,965,633 5,117
2019 Research $4,290,719 728

Breakdown

Who paid General payments · program years 2019–2020
  1. Abbott Laboratories $3,996,919 6,512 payments
Top recipients General payments · program year 2020
  1. Kevin Croce Cardiovascular Disease · Chestnut Hill, MA $96,910 9% · 50 payments
  2. Francis Zidar Interventional Cardiology · Austin, TX $50,594 5% · 61 payments
  3. Vamsi Krishna Interventional Cardiology · Kyle, TX $43,973 4% · 33 payments
  4. Aloke Finn Interventional Cardiology · Baltimore, MD $41,371 4% · 35 payments
  5. Bruce Samuels Internal Medicine · Covington, LA $39,151 4% · 33 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Interventional Cardiology Internal Medicine $541,427 56% · 156 practitioners
  2. Cardiovascular Disease Internal Medicine $350,208 36% · 81 practitioners
  3. Internal Medicine $59,651 6% · 10 practitioners
  4. Neurology Psychiatry & Neurology $3,348 <1% · 2 practitioners
  5. Vascular Surgery Surgery $2,416 <1% · 2 practitioners

The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. New York $166,320 16% · 18 recipients
  2. Texas $135,989 13% · 41 recipients
  3. California $132,585 13% · 71 recipients
  4. Rhode Island $101,910 10% · 2 recipients
  5. Georgia $60,093 6% · 5 recipients

The top 5 of 38 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

6,512 general · 777 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record